Global Interventional Oncology Devices Market Targets Growth to $3.25 Billion by 2028 [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
Market Expansion Driven by Aging Population and Technological Innovations The global interventional oncology devices market is witnessing a robust growth trajectory as it capitalizes on the aging population and cancer prevalence. Forecasts project a growth from $2.5 billion in 2024 to $3.25 billion in 2028, charting a compound annual growth rate of 6.7%. This thriving sector benefits from an increased emphasis on minimally invasive procedures, heightened R&D investments, and growth in healthcare facilities worldwide. Technological Advancements Fueling Market Development Innovation is at the forefront of market growth, with a notable focus on advanced, image-guided devices and the integration of artificial intelligence in product development. The recent FDA approval of Quantum Surgical's Epione platform underscores the integration of robotics in interventional oncology, promising greater precision and efficiency in cancer treatment procedures. Funding Influx Supports Research
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Here's Why Boston Scientific (BSX) is a Strong Momentum Stock [Yahoo! Finance]Yahoo! Finance
- Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Barclays PLC from $70.00 to $78.00. They now have an "overweight" rating on the stock.MarketBeat
- Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Citigroup Inc. from $79.00 to $85.00. They now have a "buy" rating on the stock.MarketBeat
- Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at JPMorgan Chase & Co. from $72.00 to $82.00. They now have an "overweight" rating on the stock.MarketBeat
- Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $63.00 to $73.00. They now have a "hold" rating on the stock.MarketBeat
BSX
Earnings
- 4/24/24 - Miss
BSX
Sec Filings
- 4/26/24 - Form 144
- 4/24/24 - Form 8-K
- 4/4/24 - Form 8-K
- BSX's page on the SEC website